Sally Atef Fahim

13PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical virologyHaematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 13, 2026
Anchusa azurea enhances cisplatin efficacy in oral and bone cancers through IL-17 and TNF-α pathway modulation: a metabolomic and network pharmacology approach.

|Jun 02, 2026
The paradox of miR-107 in oncology: dual roles as a tumor suppressor and oncomiR.

|Nov 27, 2025
Integrating CTLA-4 Genetics and Soluble Isoforms for the Stratification of HCV-Related Hepatocellular Carcinoma Risk and Aggressiveness.

Marwa Hassan, Walaa H El-Maadawy, Sally A Fahim

|Nov 21, 2025
Bioinformatics analysis to explore the potential prognostic utility of hsa-miR-103a-3p in head and neck squamous cell carcinoma.

Hanin Shoukry, Aliaa A Elsherbiny, Sally A Fahim

|Sep 27, 2025
Genetic Variants and Soluble Isoforms of PD-1/PD-L1 as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma (PDAC) Susceptibility and Prognosis.

Marwa Hassan, Walaa H El-Maadawy, Yasmine Elhusseny

|Jun 20, 2025
Hydroxychloroquine modulates the progression of experimentally induced benign prostatic hyperplasia in rats via targeting EGFR/ERK/STAT3 and AR/FOXO1/TRAIL pathways: computational and in vivo studies.

Walaa H El-Maadawy, Ehab Hafiz, Samer A Tadros

Pageof 3

Frequent Collaborators

2 joint publications

Marwa Hassan

1 joint publications

Samar Ibrahim

1 joint publications

Walaa H El-Maadawy

1 joint publications

Mamdouh A Ragab